Combine searches by placing the search numbers in the top search box and pressing the search button. An example search might look like (#1 or #2) and (#3 or #4)
Latest & greatest articles for otitis media
The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on otitis media or other clinical topics then use Trip today.
This page lists the very latest high quality evidence on otitis media and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.
What is Trip?
Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.
Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.
As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.
For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via firstname.lastname@example.org
Bezold's abscess: A rare complication of acute otitismediaOtitismedia is a common disease encountered in the primary practice. Most cases are successfully treated with antibiotics without any sequelae. Because of these, potential serious complications of otitismedia may be overlooked. We report a rare case of Bezold's abscess, as a complication of otitismedia and discuss its pathophysiology and management.
Montelukast versus inhaled mometasone for treatment of otitismedia with effusion in children: A randomized controlled trial Otitismedia is one of the most common infections among children and is a complication in about 30% of common colds. The most common complication of acute otitismedia is otitismedia with effusion. Some studies have reported the effects of montelukast and mometasone nasal spray in treatment of otitismedia with effusion. However, current information is inadequate (...) in this issue.To compare the effectiveness of montelukast and mometasone nasal spray in treatment of otitismedia with effusion in children attending Koodakan hospital in Bandar Abbas, Iran.This randomized controlled trial was done on 2- to 6-year-old children attending Koodakan Hospital in Bandar Abbas, southern Iran, in 2014. Patients were divided into three groups of montelukast, mometasone, and control group. Audiometry was done for all patients at baseline and four weeks after treatment. Patients were
Supplemental Project to Assess the Transparency of Reporting Requirements: Tympanostomy Tubes in Children With OtitisMedia Methods Research Report Supplemental Project To Assess the Transparency of Reporting Requirements: Tympanostomy Tubes in Children With OtitisMedia Methods Research Report Supplemental Project To Assess the Transparency of Reporting Requirements: Tympanostomy Tubes in Children With OtitisMedia Prepared for: Agency for Healthcare Research and Quality U.S. Department (...) . Supplemental Project to Assess the Transparency of Reporting Requirements: Tympanostomy Tubes in Children With OtitisMedia. Methods Research Report. (Prepared by the Brown University Evidence-based Practice Center under Contract No. 290-2015-00002-I; 290-32004-T). AHRQ Publication No. 17-EHC018-EF. Rockville, MD: Agency for Healthcare Research and Quality. June 2017. www.effectivehealthcare.ahrq.gov/reports/final.cfm. DOI: https://doi.org/10.23970/ AHRQEPCMETH2. ii Preface The Agency for Healthcare
Tympanostomy tubes in children with otitismedia Tympanostomy tubes in children with otitismedia Tympanostomy tubes in children with otitismedia Steel D, Adam GP, Di M, Halladay C, Pan I, Coppersmith N, Balk EM, Trikalinos TA Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. Citation Steel D, Adam GP, Di M, Halladay C, Pan I, Coppersmith N, Balk EM, Trikalinos TA (...) . Tympanostomy tubes in children with otitismedia. Rockville: Agency for Healthcare Research and Quality (AHRQ). Comparative Effectiveness Review No. 185. 2017 Authors' objectives The objectives for the systematic review are to synthesize information on the effectiveness of tympanostomy tubes (TT) in children with chronic otitismedia with effusion and recurrent acute otitismedia, summarize the frequency of adverse effects or complications associated with TT placement, synthesize information
Tympanostomy Tubes in Children with OtitisMedia Comparative Effectiveness Review Number 185 Tympanostomy Tubes in Children With OtitisMedia eComparative Effectiveness Review Number 185 Tympanostomy Tubes in Children With OtitisMedia Prepared for: Agency for Healthcare Research and Quality U.S. Department of Health and Human Services 5600 Fishers Lane Rockville, MD 20857 www.ahrq.gov Contract No. 290-2015-00002-I Prepared by: Brown Evidence-based Practice Center Providence, RI Investigators (...) of the report. Persons using assistive technology may not be able to fully access information in this report. For assistance contact EffectiveHealthCare@ahrq.hhs.gov. Suggested citation: Steel D, Adam GP, Di M, Halladay C, Pan I, Coppersmith N, Balk EM, Trikalinos TA. Tympanostomy Tubes in Children With OtitisMedia. Comparative Effectiveness Review No. 185. (Prepared by the Brown Evidence-based Practice Center under Contract No. 290-2015-00002-I.) AHRQ Publication No. 17-EHC003-EF. Rockville, MD: Agency
Sensorineural hearing loss in patients with chronic suppurative otitismedia: Is there a significant correlation? Hearing loss as a sequel of chronic suppurative otitismedia (CSOM) is often conductive, but recent studies have found an additional sensorineural component in these patients, thus demonstrating inner ear damage. The aim of the study was to determine the association between CSOM and sensorineural hearing loss (SNHL) and to assess the influence of patient's age, duration of disease
Otitismedia - chronic suppurative Otitismedia - chronic suppurative - NICE CKS Share Otitismedia - chronic suppurative: Summary Chronic suppurative otitismedia (CSOM) is defined as 'a chronic inflammation of the middle ear and mastoid cavity, which presents with recurrent ear discharges (otorrhoea) through a tympanic perforation’. CSOM is assumed to be a complication of acute otitismedia (AOM). The World Health Organization definition states that AOM is considered to be CSOM after at least (...) ? From age 1 month onwards. This CKS topic covers the assessment and management of suspected chronic suppurative otitismedia (CSOM) in primary care. This CKS topic does not cover advice on treatments used for CSOM in secondary care, such as antibiotics, aural cleansing, or surgery. There are separate CKS topics on , , , and . The target audience for this CKS topic is healthcare professionals working within the NHS in the UK, and providing first contact or primary health care. How up-to-date
Antibiotics for acute otitismedia in children. Acute otitismedia is one of the most common infectious diseases diagnosed in children. Antibiotic treatment use remains controversial. This summary aims to evaluate the effectiveness and safety of antibiotics in children with acute otitismedia. Searching in Epistemonikos database, which is maintained by screening 30 databases, we identified six systematic reviews including 18 randomized trials. We combined the evidence using meta-analysis (...) and generated a summary of findings table following the GRADE approach. We concluded antibiotics reduce pain at 48-72 hours and reduce the risk of tympanic perforations in children with acute otitismedia, but they do not reduce late recurrences and increase the risk of side effects (rash, vomiting and diarrhea).
Shortened Antimicrobial Treatment for Acute OtitisMedia in Young Children. Limiting the duration of antimicrobial treatment constitutes a potential strategy to reduce the risk of antimicrobial resistance among children with acute otitis media.We assigned 520 children, 6 to 23 months of age, with acute otitismedia to receive amoxicillin-clavulanate either for a standard duration of 10 days or for a reduced duration of 5 days followed by placebo for 5 days. We measured rates of clinical (...) to 23 months of age with acute otitismedia, reduced-duration antimicrobial treatment resulted in less favorable outcomes than standard-duration treatment; in addition, neither the rate of adverse events nor the rate of emergence of antimicrobial resistance was lower with the shorter regimen. (Funded by the National Institute of Allergy and Infectious Diseases and the National Center for Research Resources; ClinicalTrials.gov number, NCT01511107 .).
Impact of Pediatric Acute OtitisMedia on Child and Parental Quality of Life and Associated Productivity Loss in Malaysia: A Prospective Observational Study Acute otitismedia (AOM) affects both child and parental quality of life (QoL). Data on QoL associated with AOM in Malaysia is sparse, and the burden of indirect costs have not been previously reported.To determine the effect of pediatric AOM on child and parental QoL in Malaysia and its economic impact (indirect costs).We utilized a set
Xylitol for preventing acute otitismedia in children up to 12 years of age. Acute otitismedia (AOM) is the most common bacterial infection among young children in the United States. There are limitations and concerns over its treatment with antibiotics and surgery and so effective preventative measures are attractive. A potential preventative measure is xylitol, a natural sugar substitute that reduces the risk of dental decay. Xylitol can reduce the adherence of Streptococcus pneumoniae (S (...) daycare, there is moderate quality evidence that xylitol (in any form) can reduce the risk of AOM from 30% to around 22% compared with the control group (RR 0.75, 95% CI 0.65 to 0.88). Among the reasons for dropouts, there were no significant differences in abdominal discomfort and rash between the xylitol and the control groups. Xylitol was not effective in reducing AOM among healthy children during a respiratory infection (RR 1.13, 95% CI 0.83 to 1.53; moderate quality evidence) or among otitis
Antibiotics for otitismedia with effusion in children. Otitismedia with effusion (OME) is characterised by an accumulation of fluid in the middle ear behind an intact tympanic membrane, without the symptoms or signs of acute infection. Since most cases of OME will resolve spontaneously, only children with persistent middle ear effusion and associated hearing loss potentially require treatment. Previous Cochrane reviews have focused on the effectiveness of ventilation tube insertion (...) of ventilation tube insertion (two trials, 121 children) or in tympanic membrane sequelae (one trial, 103 children), while low quality evidence indicated that children treated with antibiotics were less likely to have acute otitismedia episodes within four to eight weeks (five trials, 1086 children; NNTB 18) and within six months post-randomisation (two trials, 199 children; NNTB 5). It should, however, be noted that the beneficial effect of oral antibiotics on acute otitismedia episodes within four
Otovent nasal balloon for otitismedia with effusion Oto Otov vent nasal balloon for otitismedia with ent nasal balloon for otitismedia with effusion effusion Medtech innovation briefing Published: 15 March 2016 nice.org.uk/guidance/mib59 pathways Summary Summary Otovent is a balloon device designed to relieve the symptoms of otitismedia with effusion, commonly known as glue ear. An Otovent kit consists of a nose piece and 5 latex balloons that are inflated by blowing through the nose. Four (...) dysfunction associated with glue ear (otitismedia with effusion), or after flying, diving or pressure chamber treatment. It would most likely be used in children with glue ear during or after an active observation period following diagnosis, to help avoid the need for surgery. Effectiv Effectiveness and safety eness and safety No relevant evidence was found for the use of Otovent in adults. Four randomised controlled trials involving a total of 565 children showed statistically significant improvements
OtitisMedia with Effusion (OME) Clinical Practice Guideline: OtitisMedia with Effusion (Update) - Richard M. Rosenfeld, Jennifer J. Shin, Seth R. Schwartz, Robyn Coggins, Lisa Gagnon, Jesse M. Hackell, David Hoelting, Lisa L. Hunter, Ann W. Kummer, Spencer C. Payne, Dennis S. Poe, Maria Veling, Peter M. Vila, Sandra A. Walsh, Maureen D. Corrigan, 2016 MENU IN THIS JOURNAL Sign In Institution Society Access Options You can be signed in via any or all of the methods shown below at the same time (...) are not available for this article. For more information view the page. double-click to add/edit rich text ... Please read and accept the and check the box to generate a sharing link. I have read and accept the terms and conditions Share URL copied to clipboard View permissions information for this article Clinical Practice Guideline: OtitisMedia with Effusion (Update) .entryAuthor" data-author-container-selector=".NLM_contrib-group"> Show all authors , MD, MPH 1 1Department of Otolaryngology, SUNY Downstate
Purulent acute otitismedia in children over 3 months Haute Autorité de Santé - Purulent acute otitismedia in children over 3 months Fermer Choose language Accessibility Change contrast : Standards Reinforced icone Chercher icone plus Chercher My account My account Please fill in your email address to retrieve your email alerts subscriptions. Please fill in your email address to retrieve your newsletter subscriptions. You do not have a saved search Sélection No element in selection Services (...) Services Déclarer un événement indésirable grave Comment déclarer les EIGS Etre accrédité par la HAS Médecins exerçant une spécialité «à risques» Déposer une demande d'évaluation d'actes Modalités et procédures Organiser les soins, les parcours Coordination des soins, coopération entre professionnels Rechercher une recommandation, un guide, un médicament Rechercher une recommandation, un médicament, un guide Date : 09 November 2016 Purulent acute otitismedia in children over 3 months Practice